Non-metastatic stage IV nasopharyngeal carcinoma patients: Analysis of the pattern of relapse and survival

Radiotherapy and Oncology

Volumn 72, Issue 1, 2004, Pages 71-77

  Özyar, Enis ^a   Gurkaynak, Murat ^a   Yildiz, Ferah ^a   Atahan, I Lale ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Nasopharyngeal carcinoma; Recurrence patterns; Stage IV

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CRANIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHILD; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS;

EID: 3242715949     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.02.012     Document Type: Article

References (32)

1. Al-Sarraf M., LeBlanc M., Giri S.P.G., et al. Chemo radiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol. 16:1998;1310-1317
2. Chan A.T.C., Teo P.M.L., Leung T.W., et al. A prospective study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 33:1995;569-577
3. Chan A.T.C., Teo P.M.L., Ngan R.K., et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in loco regionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol. 20:2002;2038-2044
4. Chau R.M., Teo P.M., Choi P.H., Cheung K.Y., Lee W.Y. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma. Radiother Oncol. 58:2001;143-153
5. Cheng S.H., Jian J.J.J., Tsai S.Y.C., et al. Long term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys. 48:2000;1323-1330
6. Cheng S.H., Yen K.L., Jian J.J.J., et al. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. Int J Radiat Oncol Biol Phys. 50:2001;717-726
7. Chi K.H., Chang Y.C., Guo W.Y., et al. A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys. 52:2002;1238-1244
8. Chien C., Chen S., Hsieh C., et al. Retrospective comparison of the AJCC 5th edition classification for nasopharyngeal carcinoma with the AJCC 4th edition: an experience in Taiwan. Jpn J Clin Oncol. 31:2001;363-369
9. Chow E., Payne D., O'Sullivan B., et al. Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an Intergroup study. Is combined modality treatment really necessary? Radiother Oncol. 63:2002;269-274
10. Chua D.T.T., Sham J.S.T., Wei W.I., Ho W., Au G.K.H. The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma. Cancer. 92:2001;2845-2855
11. Chua D.T.T., Sham J.S.T., Choy D., et al. Preliminary report of the Asian-Ocenian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregioanlly advanced nasopharyngeal carcinoma. Cancer. 83:1998;2272-2283
12. Cooper S.C., Cohen R., Stevens R.E. A comparison of staging systems for nasopharyngeal carcinoma. Cancer. 83:1998;213-219
13. Cox D.R. Regression models and life tables. J R Stat Soc B. 34:1972;187-220
14. Fleming I.D., Cooper J.S., Henson D.E., Hutter R.V.P., Kennedy B.J., Murphy G.P.,, et al. AJCC cancer staging manual. 5th ed :1997;31-39 Lippincott-Raven, Philadelphia
15. Heng D.M.K., Wee J., Fong K., et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer. 86:1999;1912-1920
16. Hong R., Ting L., Ko J., et al. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of loco regionally advanced nasopharyngeal carcinoma. J Clin Oncol. 19:2001;4305-4313
17. International Nasopharynx Cancer Study Group. VUMCA I Trial. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (>/=N2,M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys. 35:(3):1996;463-469
18. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481
19. Kutcher G.J., Fuks Z., Brenner H., et al. Three-dimensional photon treatment planning for carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys. 21:1991;169-182
20. Kwong D.L., Sham J.S., Au G.K. Preliminary report on a randomized controlled trial of concomitant UFT/radiation and adjuvant chemotherapy for loco regionally advanced non-metastatic nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 51:2001;42
21. Lee A.W.M., Sze W.M., Yau T.K., Yeung R.M.W., Chappell R., Fowler J.F. Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity. Radiother Oncol. 58:2001;121-130
22. Levendag P.C., Lagerwaard F.J., de Pan C., et al. High-dose, high-precision treatment options for boosting cancer of the nasopharynx. Radiother Oncol. 63:2002;67-74
23. Ma J., Mai H., Hong M., et al. Results of prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with loco regionally advanced nasopharyngeal carcinoma. J Clin Oncol. 19:2001;1350-1357
24. Özyar E., Yildiz F., Akyol F.H., Atahan I.L. Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 44:1999;1079-1088
25. Özyar E., Yildiz F., Akyol F.H., Atahan İ.L. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 52:2002;101-108
26. Rossi A., Molinari R., Boracchi P., et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter study. J Clin Oncol. 6:1988;1401-1410
27. Sobin L.H., Wittekind C. UICC TNM classification of malignant tumors. 6th ed :2002;27-35 Wiley-Liss, New York
28. Sultanem K., Shu H., Xia P., et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California - San Francisco experience. Int J Radiat Oncol Biol Phys. 48:2000;711-722
29. Tate D.J., Adler J.R. Jr, Chang S.D., et al. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. Int J Radiat Oncol Biol Phys. 45:1999;915-921
30. Teo P., Yu P., Lee W.Y., et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys. 36:1996;291-304
31. Teo P.M.L., Chan A.T.C., Lee W.Y.L., Leung T.W.T., Johnson P.J. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy. Int J Radiat Oncol Biol Phys. 43:1999;261-271
32. Waldron J., Tin M.M., Keller A., et al. Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma. Radiother Oncol. 68:2003;153-161